Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes - Wikidata - thesis-toulmin - TriplyDB

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

http://www.wikidata.org/entity/Q28369463

about

Insulin sensitizing effects of oligomannuronate-chromium (III) complexes in C2C12 skeletal muscle cells Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes.Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes.Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue Lipid composition of cell membranes and its relevance in type 2 diabetes mellitus Defect of insulin signal in peripheral tissues: Important role of ceramide Omega-3 Fatty Acids and Skeletal Muscle Health Acetylation of TUG protein promotes the accumulation of GLUT4 glucose transporters in an insulin-responsive intracellular compartment Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4 Prevention of fat-induced insulin resistance by salicylate Insulin resistance and the disruption of Glut4 trafficking in skeletal muscle The Krüppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4 Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle Mice deficient in the insulin-regulated membrane aminopeptidase show substantial decreases in glucose transporter GLUT4 levels but maintain normal glucose homeostasis Cellular mechanisms of insulin resistance Mechanisms for insulin resistance: common threads and missing links Identification of amino acid residues within the C terminus of the Glut4 glucose transporter that are essential for insulin-stimulated redistribution to the plasma membrane.Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism Dipolar coupling and ordering effects observed in magnetic resonance spectra of skeletal muscle.Studies of metabolic compartmentation and glucose transport using in vivo MRS.Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body.MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST).Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes.Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments Metabolic Remodeling in Diabetic Cardiomyopathy.Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice Myostatin expression, lymphocyte population, and potential cytokine production correlate with predisposition to high-fat diet induced obesity in mice.Pathogenesis of insulin resistance in skeletal muscle.Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans A polymer-based ratiometric intracellular glucose sensor A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes.Remodeling lipid metabolism and improving insulin responsiveness in human primary myotubes.Diacylglycerol-mediated insulin resistance.Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.A metabonomic comparison of urinary changes in Zucker and GK rats.

P2860

Q21135221-3DE78D5F-9EA2-4D2F-BAC6-9CE66DD91BD0 Q24535576-1AE9BCA4-8EE0-4D78-AF12-1E36282A1C7E Q24535742-D1558120-FB99-4EF5-A688-70DBCAD80999 Q24629603-814A91E9-3628-4C2B-8C89-C5F09228F305 Q24632414-6EEEE4EB-E9EC-4491-A289-FB0DB91FE1A3 Q24685655-53CF87AE-4CE6-4C68-ABB1-DBC60FA5B60D Q24812499-6C104163-42A5-486D-A491-657043CD2ACB Q25257247-91A085EC-FB12-42D8-9EEA-DCE3C363FB73 Q26830631-24D44F57-0AD5-4189-9340-2261EB38B047 Q27016081-988FF952-3030-4D30-AA43-ABFE02BBD582 Q27690875-2ED90F3A-6076-44A3-A164-A92A9B4F772D Q28084892-70C779E4-8897-464C-8F1C-B1FE454376DB Q28254967-B8BDBC02-AC6E-4628-A07C-774287B2BD0D Q28343432-DE4D0DA6-594E-4591-B696-523E433FB4CE Q28345600-A9F8E416-6B93-4025-AF74-FDEC9712A3E6 Q28365876-9CD1700C-8A19-462C-92E4-9D67F5FD8068 Q28585457-3A90F61A-27AF-4BC6-A204-C53C2E00D816 Q28586493-D54DD25A-0186-4F73-A42D-5ED8A57901DB Q28589946-38737A58-C9B9-47D3-8C52-13B62076E272 Q29619549-C60A2DEB-B876-4D93-9E86-4D3CEC49725E Q29620447-AC3D8F2C-EB6B-4796-A786-A22A05E6ED72 Q30439704-0DF60537-9F0E-45C0-8907-68F05FA769D2 Q30447386-835BF67E-48A8-4564-B010-E278C330A49C Q30650334-F0CAE00E-CE8E-47E4-8A68-C80CEC0458D4 Q30650337-023DEAF9-C73A-48B3-80E9-203FD71F07F0 Q30991322-DE5CD687-667F-4B13-8597-E9AB38533AF6 Q31105578-EF676F8A-4BEA-4764-9CE4-971B16F68802 Q33283340-D74AA4BC-7475-4262-B030-59C259B2E4AA Q33428661-4A824CFF-3651-40A5-9C80-6A43C9FA9516 Q33623469-B4A35C9B-4C64-48C3-92AF-1491BA9AEDE9 Q33697550-9BEAE12E-BF1F-46EC-8919-F62AA0F69FED Q33705132-2022DD7F-8089-432B-80F1-7945A7EAB7B6 Q33812448-39866DB4-8A18-4F60-89D0-3543DA83CB9C Q33854029-5288CC6F-6B22-4665-ACFE-48737D50E7BA Q33887300-429A7A3F-0F8C-4022-8FCF-1EA4CC06CC24 Q33954068-0C0175D4-EF37-43BB-BE45-2411935FFF0A Q33961423-2F3A14F7-A14F-4AE4-801D-67BA15A31D5A Q34109119-BDE27B5F-1C7F-45EA-A917-D5012426C79D Q34126257-632FC185-7648-4D1C-B605-09E4A15ADAFE Q34239102-21320A83-A0F4-4A1F-95A0-FCFE710E8E44

P2860

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

http://www.wikidata.org/entity/Q28369463

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@ast

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@en

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@nl

type

label

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@ast

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@en

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@nl

prefLabel

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@ast

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@en

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@nl

P1433

Q28369463-45A6F828-064D-48E7-B9B8-7761FE012138

P1476

Q28369463-20671A45-CAB1-4B1F-AB3A-B09D1F3CFF28

P2093

Q28369463-2BE7FD96-BE7E-4441-97B0-0775B8FE124D

Q28369463-3FECFF3B-9554-468A-BB47-BF5954C81911

Q28369463-5764F251-0528-435F-84C1-484B1B9ECE72

Q28369463-8E8C9AC6-EB7E-413F-A728-147C7170499B

Q28369463-91DFCF09-3FB9-4B34-BF86-C03719C0728D

Q28369463-B37F61D5-FC2E-4EFA-BF1C-4A494567C34E

Q28369463-B7495CFB-2B86-4D8D-BB7E-FC51BC6AD499

Q28369463-CFEF449C-FB17-4098-8BA6-C86DC72F9900

Q28369463-DE10CE35-BD43-44CD-94DB-30FF7BED00A2

Q28369463-E5D9E460-3A9B-4565-B9B9-6C517BAF8862

P304

Q28369463-4AFAF947-ACD4-4D85-AB48-649E90A0E0C0

P31

Q28369463-8E637DEC-CF94-4895-81B8-324147123634

P3181

Q28369463-01912D7A-FDB0-43A0-8467-C4D9E85C6880

P356

Q28369463-AF6C9DE8-5E48-4C67-9FD3-73A02067C5BA

P407

Q28369463-3E8C1F4C-226F-4A8A-8CD3-1BFE95F97FB4

P433

Q28369463-6A9582AE-E3F8-4503-8A89-64C2E6452401

P478

Q28369463-6312CF4E-A7E3-4A39-AF0B-35FD52BB5378

P577

Q28369463-8B794F93-73CE-40CD-940C-03588F29821C

P5875

Q28369463-EB7116C2-67B3-40F3-90FD-137603DB1EA8

P698

Q28369463-0E50B071-52D9-442D-89D7-4AC543592892

P921

Q28369463-77D8F670-3912-4A07-90B2-F82155030A10

Q28369463-D2404B01-CD38-4535-A116-B0A273C9C9F7

Q28369463-ecf67116-4171-4908-bae3-8464f8b9bbd9

P3181

P356

NEJM199907223410404

P1433

The New England Journal of Medicine

P1476

Impaired glucose transport as ...... n synthesis in type 2 diabetes

@en

P2093

A Dresner

http://www.w3.org/2001/XMLSchema#string

D L Rothman

http://www.w3.org/2001/XMLSchema#string

G I Shulman

http://www.w3.org/2001/XMLSchema#string

G W Cline

http://www.w3.org/2001/XMLSchema#string

J Shen

http://www.w3.org/2001/XMLSchema#string

K F Petersen

http://www.w3.org/2001/XMLSchema#string

M Krssak

http://www.w3.org/2001/XMLSchema#string

R S Hundal

http://www.w3.org/2001/XMLSchema#string

S Inzucchi

http://www.w3.org/2001/XMLSchema#string

Z Trajanoski

http://www.w3.org/2001/XMLSchema#string

P304

240-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2288108

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJM199907223410404

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

341

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12885228

http://www.w3.org/2001/XMLSchema#string

P698

10413736

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes